The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.
A new oral medication, called infigratinib, shows promise in enhancing growth and limb proportion in children with ...
Medically reviewed by Jonathan Purtell, RDNVitamin C (ascorbic acid) is a water-soluble vitamin that cannot be stored in the ...